( NASDAQ-SMALL:ROSG )

News from Rosetta Genomics Ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 12, 2009, 08:30 ET Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

Rosetta Genomics Ltd. (Nasdaq:ROSG) reported today the first ever in-vivo efficacy data for a systemic microRNA-based cancer therapeutic....


Jan 16, 2009, 08:30 ET Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum

Rosetta Genomics Ltd. (Nasdaq:ROSG) and collaborators, today unveiled initial data relating to the company's colorectal cancer screening...


Dec 29, 2008, 08:30 ET Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso

Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today the introduction of its third...


Dec 22, 2008, 08:00 ET Rosetta Genomics Announces Commercial Availability of its Second MicroRNA-Based Diagnostic Test - miRview(TM) mets; Will Hold Teleconference Today to Discuss Launch of Products

Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today the commercial availability of...


Dec 11, 2008, 09:07 ET Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests

Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today the commercial availability of...


Dec 05, 2008, 16:30 ET Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference

Rosetta Genomics Ltd (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it will...


Dec 05, 2008, 07:30 ET Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS

Rosetta Genomics, Ltd. (NASDAQ: ROSG), an innovative molecular diagnostic company leveraging microRNAs as biomarkers, reported today its...


Dec 02, 2008, 06:21 ET /C O R R E C T I O N -- Rosetta Genomics Ltd/

In the news release, "Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results" issued on 26 Nov 2008 21:30 GMT,...


Nov 26, 2008, 16:30 ET Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results

Rosetta Genomics (Nasdaq: ROSG), today announced it will release third quarter financial results on December 5, 2008, before the U.S. markets open....


Nov 06, 2008, 10:39 ET /C O R R E C T I O N -- Rosetta Genomics Ltd/

In the news release, "Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference" issued on 5 Nov 2008 13:30 GMT, by...


Nov 03, 2008, 08:01 ET Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference

Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics, announced today it will present at AACR's...


Sep 29, 2008, 01:00 ET Rosetta Genomics is the Winner of the Medical-Biotech Category in This Year's Wall Street Journal Technology Innovation Awards

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG) has been named this year's winner of the Medical-Biotech category in the Wall...


Sep 24, 2008, 01:00 ET Rosetta Genomics to Present at Maxim Group Growth Conference

/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics, announced today its...


Sep 23, 2008, 01:00 ET Rosetta Genomics Announces Transfer of MicroRNA-based Liver Therapeutics Project With Isis Pharmaceuticals, Inc. to Regulus Therapeutics LLC

/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics,...


Sep 18, 2008, 01:00 ET MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma

/PRNewswire-FirstCall/ -- - A Collaborative Study by Scientists at the Weizmann Institute of Science and Scientists at Sheba Medical Center,...


Sep 05, 2008, 01:00 ET Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic...


Aug 20, 2008, 01:00 ET Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today a collaboration with the National Institute of Health to identify...


Aug 19, 2008, 01:00 ET Rosetta Genomics Reports Second Quarter 2008 Financial Results

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based diagnostic and therapeutic products,...


Jul 24, 2008, 01:00 ET Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.

/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics,...


Jul 09, 2008, 01:00 ET Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic...


Jul 03, 2008, 01:00 ET Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference

/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (Nasdaq: ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced...


Jun 25, 2008, 01:00 ET Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), announced today a collaboration with the Rabin Medical Center in Israel to...


Jun 25, 2008, 01:00 ET Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), announced today that Tamir Kazaz, the Company's CFO for the last two and a half...


Jun 06, 2008, 01:00 ET Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer

/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic...


May 14, 2008, 01:00 ET Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results

/PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on May 21, 2008,...